Cargando…

GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis

G2 and S phase-expressed-1 (GTSE1) regulates G1/S cell cycle transition. It was recently reported to be overexpressed in certain human cancers, but its significance and mechanism(s) in hepatocellular carcinoma (HCC) remain unknown. Here, we showed preferential GTSE1 upregulation in human HCC tissues...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xiaojuan, Wang, Hongbo, Lian, Yifan, Chen, Lubiao, Gu, Lin, Wang, Jialiang, Huang, Yanlin, Deng, Meihai, Gao, Zhiliang, Huang, Yuehua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505986/ https://www.ncbi.nlm.nih.gov/pubmed/28698581 http://dx.doi.org/10.1038/s41598-017-05311-2

Ejemplares similares

Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma
por: Huang, Yanlin, et al.
Publicado: (2018)

Downregulated Trophinin-Associated Protein Plays a Critical Role in Human Hepatocellular Carcinoma Through Upregulation of Tumor Cell Growth and Migration
por: Lian, Yifan, et al.
Publicado: (2018)

Prognostic roles of the transcriptional expression of exportins in hepatocellular carcinoma
por: Chen, Lubiao, et al.
Publicado: (2019)

HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression
por: Chen, Lubiao, et al.
Publicado: (2016)

Correlations between cytokines produced by T cells and clinical-virological characteristics in untreated chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2019)

Synergistic effect of farnesyl transferase inhibitor lonafarnib combined with chemotherapeutic agents against the growth of hepatocellular carcinoma cells
por: Wang, Jialiang, et al.
Publicado: (2017)

CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
por: Gu, Yurong, et al.
Publicado: (2020)

Overexpressing CCT6A Contributes To Cancer Cell Growth By Affecting The G1-To-S Phase Transition And Predicts A Negative Prognosis In Hepatocellular Carcinoma
por: Zeng, Guofen, et al.
Publicado: (2019)

Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment
por: Chen, Lubiao, et al.
Publicado: (2018)

GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer
por: Zheng, Yongchang, et al.
Publicado: (2019)

GTSE1 promotes SNAIL1 degradation by facilitating its nuclear export in hepatocellular carcin oma cells
por: Li, Shan-Shan, et al.
Publicado: (2021)

Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells
por: Guo, Lei, et al.
Publicado: (2016)

The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells
por: Wang, Jialiang, et al.
Publicado: (2019)

High GTSE1 expression promotes cell proliferation, metastasis and cisplatin resistance in ccRCC and is associated with immune infiltrates and poor prognosis
por: Lei, Pu, et al.
Publicado: (2023)

Correction for: The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells
por: Wang, Jialiang, et al.
Publicado: (2019)

Pan-Cancer Landscape of NEIL3 in Tumor Microenvironment: A Promising Predictor for Chemotherapy and Immunotherapy
por: Liao, Weixin, et al.
Publicado: (2022)

Serum HBV pregenomic RNA is correlated with Th1/Th2 immunity in treatment‐naïve chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2019)

Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B
por: Gu, Yurong, et al.
Publicado: (2020)

High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Xu, Wenxiong, et al.
Publicado: (2022)

Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment
por: Li, Xiaoyan, et al.
Publicado: (2017)

GTSE1 Is a Microtubule Plus-End Tracking Protein That Regulates EB1-Dependent Cell Migration
por: Scolz, Massimilano, et al.
Publicado: (2012)

GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner
por: Lin, Fen, et al.
Publicado: (2019)

Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
por: Zhu, Zebin, et al.
Publicado: (2018)

GTSE1 is possibly involved in the DNA damage repair and cisplatin resistance in osteosarcoma
por: Xie, Chaofan, et al.
Publicado: (2021)

Pan-cancer analyses reveal GTSE1 as a biomarker for the immunosuppressive tumor microenvironment
por: Tan, Ke, et al.
Publicado: (2023)

GTSE1 promotes the growth of NSCLC by regulating microtubule‐associated proteins through the ERK/MAPK pathway
por: Wang, Chuanlin, et al.
Publicado: (2023)

The lncRNA PCAT1 is correlated with poor prognosis and promotes cell proliferation, invasion, migration and EMT in osteosarcoma
por: Zhang, Xuedong, et al.
Publicado: (2018)

Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma
por: Wang, Jialiang, et al.
Publicado: (2023)

GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells
por: Subhash, Vinod Vijay, et al.
Publicado: (2015)

GTSE1 tunes microtubule stability for chromosome alignment and segregation by inhibiting the microtubule depolymerase MCAK
por: Bendre, Shweta, et al.
Publicado: (2016)

An Immuno-Clinic score model for evaluating T cell immunity and predicting early antiviral therapy effectiveness in chronic hepatitis B
por: Gu, Yurong, et al.
Publicado: (2020)

Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma
por: Sun, Yifan, et al.
Publicado: (2017)

Overexpression of long noncoding RNA LINC00882 is associated with poor prognosis in hepatocellular carcinoma
por: Zhu, Lei, et al.
Publicado: (2018)

Soluble programmed death‐1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B
por: Zhou, Liang, et al.
Publicado: (2019)

CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells
por: Huang, Xiaoting, et al.
Publicado: (2021)

Up-regulated and interrelated expressions of GINS subunits predict poor prognosis in hepatocellular carcinoma
por: Lian, Yi-Fan, et al.
Publicado: (2018)

Increased ATG5 Expression Predicts Poor Prognosis and Promotes EMT in Cervical Carcinoma
por: Zhou, Suna, et al.
Publicado: (2021)

RPS24 Is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma
por: Li, Haiyuan, et al.
Publicado: (2023)

CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis
por: Gu, Xuefeng, et al.
Publicado: (2019)

GTSE1 Facilitates the Malignant Phenotype of Lung Cancer Cells via Activating AKT/mTOR Signaling
por: Zhang, Fan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n56asu1rblnvl9oh9pcpe428pa